About: pharmaceuticals

Health 01-10-2018

Europe’s health sector worried about post-Brexit investment dearth

Fragmented, multilingual and over-regulated: Europe is currently not an attractive place for investors and things could get worse after Brexit, experts from the life sciences industry have warned.
Economy & Jobs 16-08-2018

Bayer loses €16 bln market value as concerns mount over further damages claims

Bayer shares registered yet another sharp decrease on Thursday (16 August), dropping as much as 6.5% in Frankfurt to hover near the 76 euros level as investors fear the German chemicals and pharmaceuticals giant may face numerous litigations in the US after its controversial merger with Monsanto. 
Health 20-12-2017

Pharma firms face multi-million Brexit bill, MPs warned

Pharmaceutical companies face a multi-million euro bill in regulatory costs regardless of whether the UK reaches a ‘soft’ or ‘hard’ Brexit deal with the European Union, industry leaders warned on Tuesday (19 December).
Health 13-10-2017

New Commission study fuels generic drugs industry ‘manufacturing dispute’

The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.
Health 12-10-2017

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
Health 21-03-2017

Commission silent over Hungary’s pharmacy ownership law

EXCLUSIVE / An EU infringement procedure launched against Hungary about a law that regulates pharmacies has been unjustifiably stalled for more than two years, raising concerns among foreign investors.
Agrifood 24-01-2017

EU remains idle on curbing imports of ‘blood farm’ hormones

The European Commission has remained silent over a cruel but perfectly legal practice, common in South America, of rearing pregnant horses for their blood in order to harvest a hormone that is used in veterinary products imported to Europe. EURACTIV Germany reports.
Health 20-01-2017

OECD criticises ‘ineffective spending’ in healthcare

Health spending in countries that belong to the Organisation for Economic Cooperation and Development (OECD) is "at best ineffective and at worst wasteful", a new report has found.
Health 21-10-2016

Andriukaitis: Health Technology Assessment will make EU healthcare ‘sustainable’

EXCLUSIVE / National healthcare systems should embrace the digital era and use Health Technology Assessment (HTA) to become truly sustainable and cost-effective, European Commissioner for Health and Food Safety Vytenis Andriukaitis told EURACTIV.com in an interview.
Health 28-09-2016

Parliament wants harmonised criteria for drug pricing and reimbursement

The European Parliament will seek an increased EU role in regulating the pharmaceutical market and controlling rising drug prices, according to a draft report seen by EURACTIV.com.
Antibiotics
Health 11-12-2015

Pharma pollution is overlooked cause of antimicrobial resistance

Unused pharmaceuticals, which end up in the environment, such as in groundwater, pose a major threat to public health and the environment, by leading to the development of antimicrobial resistance (AMR) in humans.
Health 05-11-2015

Germans spend more on medicine than most of Europe

Expenditure on medicinal drugs in Germany is higher than in most other European countries, according to the OECD. EURACTIV Germany reports.
Health 02-09-2015

Big pharma complains about French law pushing cheap eye drug

Europe's pharmaceuticals industry said on Tuesday (1 September) it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as an alternative to more expensive eye treatments.
Health 14-07-2015

Hackers develop innovative treatments for chronic illnesses

Medical companies are turning to hackers to develop the next generation of electronic health applications to treat chronic illnesses. EURACTIV France reports.

Biopharmaceuticals booming in Germany despite GMO controversy

Modern pharmaceuticals are no longer exclusively produced in a chemicals laboratory, but are often developed using live cells. In Germany, such biopharmaceuticals are being sold and prescribed at an ever increasing rate – despite widespread scepticism over GMOs in Germany. EURACTIV Germany reports.
Health 17-06-2015

Germany ranked among Europe’s biggest pharma spenders

A recent European comparison shows Germany’s expenditures on pharmaceuticals are above average. No other country offers medications for treating illnesses “as quickly and comprehensively” as the Federal Republic. EURACTIV Germany reports.
Health 10-03-2015

Paracetamol may increase risk of cardiovascular disease

Paracetamol tablets are the world’s most commonly used painkillers. According to a recent study published in the British journal Annals of the Rheumatic Diseases, prolonged use of the drug can have very harmful side effects. EURACTIV France reports
Health 19-02-2015

German study finds prevalence of prescriptions without benefit

Doctors in Germany often prescribe medications without any proof of additional benefit, a recent study indicates, revealing that the reasons behind this are unscientific. EURACTIV Germany reports.
Health 22-10-2014

Juncker u-turn puts pharma in health Commissioner’s portfolio

Pharmaceutical drugs, and medical technology, will remain under the department of health (DG Sanco) in the next Commission, Jean-Claude Juncker, the President-elect, confirmed on Wednesday (22 October).
Health 10-10-2014

Juncker seen making U-turn on medicines policy

Jean-Claude Juncker has ceded to pressure from MEPs and abandoned his plan to return control of medicines and pharmaceutical products to the Industry Commissioner. This responsibility will instead remain in the hands of the Health Commissioner, EURACTIV France reports
Research
Health 29-09-2014

Pharma industry denies it lobbied for medicines to move to DG Enterprise

Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).

Berlin launches dialogue to boost pharma research

The German government initiated plans on Monday (15 September) to strengthen the country’s attractiveness for pharmaceutical research and development, but the Left Party warns it is likely to become an "image campaign" for pharmaceutical giants. EURACTIV.de reports.
31 drugs intended to treat cancer were approved by the European Medicines Agency (EMA) over the past three years. 2011 [Interpharma/Flickr]

Cancer research at a crossroads in Germany

A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EURACTIV Germany reports.
Development Policy 05-02-2014

MSF Director: ‘We are losing the battle’ for cheap drugs in developing world

José Antonio Bastos, head of doctors without borders (MSF) in Spain, has spoken out against big pharmaceutical companies that "only think in terms of profit" and pay little attention to "real health needs" of the population in developing countries, EURACTIV Spain reports.